ARCHIVES

Evaluation Finds OIG Provides PIs With Flexibility

This article is from The Cancer Letter archive.

Vol. 17 No. 24 | June 14, 1991

Download PDF Visit The Full Archive

Related Articles

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993

DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program

February 24, 1984

Gene Vector Labs Seek Vector Producers

February 23, 1996

AACI Statement On Cancer Centers Presented to Reform Task Force

April 9, 1993

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014